Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
9.9%
% of IXJ's 111 holdings also in MEDX
36.7%
% of MEDX's 30 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.1% | 15.9% | 8.1% |
|
JOHNSON & JOHNSON | 5.0% | 4.9% | 4.9% |
|
ABBVIE INC | 4.3% | 8.6% | 4.3% |
|
MERCK & CO. INC. | 3.5% | 4.3% | 3.5% |
|
PFIZER INC | 2.1% | 4.5% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 6.7% |
 |
NOVO NORDISK A/S-B | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
 |
ASTRAZENECA PLC | 2.9% |
 |
ROCHE HOLDING LTD | 2.9% |
|
ABBOTT LABORATORIES | 2.8% |
|
NOVARTIS AG | 2.8% |
|
DANAHER CORP | 2.2% |
|
BOSTON SCIENTIFIC CORP | 2.1% |
IXJ Underweight Relative to MEDX
|
ELI LILLY & CO | -7.8% |
|
NOVARTIS AG-ADR | -6.1% |
|
ASTRAZENECA PLC-SPONS ADR | -5.4% |
|
BRISTOL-MYERS SQUIBB CO | -4.9% |
|
ALNYLAM PHARMACEUTICALS INC | -4.6% |
 |
ALKERMES PLC | -4.4% |
|
ABBVIE INC | -4.3% |
|
AMGEN INC | -3.9% |
|
CRISPR THERAPEUTICS AG | -2.8% |
|
BIOGEN IDEC INC | -2.6% |